ISIS 388626
/ Ionis
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 28, 2011
Isis reports financial results and highlights for 2010
(PRNewswire)
-
Isis plans to complete and report P1 data of ISIS-SGLT2Rx and begin P2 programs for ISIS-CRPRx and ISIS-SGLT2Rx; Company reported a loss from operations of $15.9M and $48.4M for Q4 & FY ‘10 respectively, vs. a loss from operations of $11.7M and $27.5M for Q4 & FY ‘09, respectively
Diabetes
1 to 1
Of
1
Go to page
1